A drug company is performing tests of its generic drug to determine the rate and extent of the action of a compound in the body. The company wants to compare this drug to a brand-name drug. What will these experiments tell them?

Testing the rate and extent at which the active compound becomes available in the body measures the drugs’ bioavailability. Comparing these measurements for a generic and brand-name drug shows whether they are bioequivalent. These tests do not determine patent status or, by themselves, whether either drug has FDA approval.

AI-written and checked against the verified answer.